Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis.
暂无分享,去创建一个
T. Kozel | J. Jarvis | A. Percival | S. Bauman | J. Pelfrey | G. Meintjes | G. Williams | N. Longley | T. Harrison | Ann Percival | Joseph N Jarvis | Thomas S Harrison | Sean Bauman | Joy Pelfrey | Graeme Meintjes | G Ntombomzi Williams | Nicky Longley | Thomas R Kozel | GN Williams
[1] D. Boulware,et al. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] S. S. Olmsted,et al. Requirements for high impact diagnostics in the developing world , 2006, Nature.
[3] F. Dromer,et al. Evaluation of a monoclonal antibody-based latex agglutination test for diagnosis of cryptococcosis: comparison with two tests using polyclonal antibodies , 1992, Journal of clinical microbiology.
[4] P. Tebas,et al. The Use of HAART Is Associated With Decreased Risk of Death During Initial Treatment of Cryptococcal Meningitis in Adults in Botswana , 2008, Journal of acquired immune deficiency syndromes.
[5] N. Khardori. High-Dose Amphotericin B with Flucytosine for the Treatment of Cryptococcal Meningitis in HIV-Infected Patients: A Randomized Trial , 2008 .
[6] S. Lawn,et al. Cryptococcal antigen screening for patients initiating antiretroviral therapy: time for action. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] N. French,et al. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults , 2002, AIDS.
[8] L. Bekker,et al. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] M. Weinstein,et al. Comparison of commercial kits for detection of cryptococcal antigen , 1994, Journal of clinical microbiology.
[10] R. Wood,et al. Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme. , 2010, AIDS.
[11] J. Jarvis,et al. Cryptococcal meningitis--a neglected killer. , 2011, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[12] C. Chernecky. In vitro connector research. , 2010, Clinical Infectious Diseases.
[13] J. Jarvis,et al. Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases , 2010, BMC infectious diseases.
[14] S. Edberg,et al. Cryptococcal antigen detection from the urine of AIDS patients. , 1993, Diagnostic microbiology and infectious disease.
[15] Y. Germani,et al. Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus. , 2006, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[16] Suzanne M. Brandt,et al. Monoclonal Antibodies Reactive with Immunorecessive Epitopes of Glucuronoxylomannan, the Major Capsular Polysaccharide of Cryptococcus neoformans , 2003, Clinical Diagnostic Laboratory Immunology.
[17] T. Kozel,et al. Monoclonal Antibodies Specific for Immunorecessive Epitopes of Glucuronoxylomannan, the Major Capsular Polysaccharide of Cryptococcus neoformans, Reduce Serotype Bias in an Immunoassay for Cryptococcal Antigen , 2011, Clinical and Vaccine Immunology.
[18] S. Lawn,et al. Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts--time to implement in South Africa? , 2011, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[19] S. Lawn,et al. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] C. Whitty,et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. , 2007, The New England journal of medicine.
[21] J. Jarvis,et al. Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa. , 2010, The Journal of infection.
[22] K. Wannemuehler,et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS , 2009, AIDS.